Evidence map›Paper›PMID 37359719›Full record

ArticleClinical, cosmetic and investigational dermatology2023

Alterations of Autophagy Modify Lipids in Epidermal Keratinocytes.

Qingwei Geng, Guoqi Wei, Yebei Hu, Jinhui Xu, Xiuzu Song

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qingwei Geng *Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, 310009, People's Republic of China.
Guoqi Wei *Hangzhou Fuyang Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, 322499, People's Republic of China.
Yebei HuDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, 310009, People's Republic of China.
Jinhui XuDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, 310009, People's Republic of China.
Xiuzu SongDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, 310009, People's Republic of China.
Third People's Hospital of Hangzhou · CNHangzhou Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The skin barrier is the first line of defense of the body, while skin lipids play an important role in the skin permeability barrier. Lamellar bodies are also involved in maintaining the stability of the skin permeability barrier. However, the exact origin of lamellar bodies remains unclear. Recent studies have suggested that autophagy may participate in the formation of lamellar bodies. Aim: This study aimed to investigate the role of autophagy in the formation of lamellar bodies in keratinocytes and the regulation of keratinocyte lipids. Methods: Keratinocytes were incubated with autophagy inducer Rapamycin and autophagy inhibitor Bafilomycin A1. The changes in autophagy flux were detected by Western blot, and the formation of lamellar bodies was observed by transmission electron microscopy. Furthermore, the changes in keratinocytes lipidomics were detected by liquid chromatography-mass spectrometry. Results: Our research showed that the autophagy inducer promoted autophagy activation and formation of lamellar bodies in keratinocytes, while the inhibitor inhibited autophagy signals and the formation of lamellar bodies in keratinocytes. In addition, the lipidomics results revealed a significant change in glycerophospholipids after autophagy induction and autophagy inhibition. Conclusion: These results demonstrate that autophagy may play an essential role in skin lipids via glycerophospholipids pathway.

Indexed as

Bafilomycin A1keratinocyteslipidliquid chromatography-mass spectrometryrapamycinskin barrier

Identifiers

PMID37359719
PMCPMC10290458
OpenAlexW4381436464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.